At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CAMP Camp4 Therapeutics Corp.
Trading 07-23 13:10:20 EDT
3.06
-0.05
-1.75%
High3.21Low2.94Vol122.00K
Open3.11D1 Closing3.11Amplitude8.68%
Mkt Cap158.53MTradable Cap83.93MTotal Shares51.88M
T/O365.69KT/O Rate0.44%Tradable Shares27.47M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Camp4 Therapeutics Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
THOMSON REUTERS  ·  07-18
Camp4 Therapeutics Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan
TIPRANKS  ·  06-23
Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan
Camp4 Therapeutics grants 39,000 inducement stock options at $3.96 per share
Reuters  ·  06-20
Camp4 Therapeutics grants 39,000 inducement stock options at $3.96 per share
Camp4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
THOMSON REUTERS  ·  06-20
Camp4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Sector Update: Healthcare
MT Newswires Live  ·  06-17
Sector Update: Healthcare
Discovr Radio to Embed Across All Four Days of CAMP Toronto in First Major Activation with Beatcave
GlobeNewswire  ·  06-16
Discovr Radio to Embed Across All Four Days of CAMP Toronto in First Major Activation with Beatcave
Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan
TIPRANKS  ·  06-16
Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation
Reuters  ·  06-16
U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
TIPRANKS  ·  06-13
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting
Reuters  ·  06-13
Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting
CAMP4 Therapeutics Initiated at Buy by Chardan Capital
Dow Jones  ·  06-10
CAMP4 Therapeutics Initiated at Buy by Chardan Capital
Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target
MT Newswires Live  ·  06-10
Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target
Camp4 Therapeutics initiated with a Buy at Chardan
TIPRANKS  ·  06-10
Camp4 Therapeutics initiated with a Buy at Chardan
U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle
Reuters  ·  06-10
U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle
CAMP4 Therapeutics Corporation (CAMP) Receives a New Rating from Chardan Capital
TIPRANKS  ·  06-10
CAMP4 Therapeutics Corporation (CAMP) Receives a New Rating from Chardan Capital
Camp4 Therapeutics Corp : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $6.5
THOMSON REUTERS  ·  06-10
Camp4 Therapeutics Corp : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $6.5
U.S. big tech holds 85% of Canadian cloud market, report says ahead of AI strategy
Bloomberg  ·  06-02
U.S. big tech holds 85% of Canadian cloud market, report says ahead of AI strategy
Camp4 Therapeutics grants inducement option for 5,000 shares at $4.31 exercise price
Reuters  ·  05-22
Camp4 Therapeutics grants inducement option for 5,000 shares at $4.31 exercise price
Camp4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
THOMSON REUTERS  ·  05-22
Camp4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
TIPRANKS  ·  05-14
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy

Introduction

Company Name.
Camp4 Therapeutics Corp.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--